tirzepatide clinical trial SURMOUNT-3 study design This is a phase 3, multicenter, randomized, Tirzepatide for Weight Loss |

Some early work reported favorable effects on fat metabolism, while larger later trials did not produce the weight loss outcomes needed for approval

If cholelithiasis is suspected, gallbladder diagnostic studies and appropriate clinical follow-up are indicated Tell your healthcare provider right away if you get symptoms of gallbladder problems which may include: pain in your upper stomach (abdomen) fever yellowing of skin or eyes (jaundice) clay-colored stools Low Blood Sugar (Hypoglycemia) Your risk for getting low blood sugar may be higher if you use Zepbound with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin Signs and symptoms of low blood sugar may include: dizziness or light-headedness sweating confusion or drowsiness headache blurred vision slurred speech shakiness fast heartbeat anxiety, irritability, or mood changes hunger weakness feeling jittery Concomitant use with an insulin secretagogue (e.g., sulfonylurea) or insulin may increase the risk of hypoglycemia, including severe hypoglycemia The risk of hypoglycemia may be lowered by reducing the dose of sulfonylurea (or other concomitantly administered insulin secretagogue) or insulin

To help prevent skin irritation, its important to rotate the injection site each week

P = .004) than adults using metformin

KEY POINTS Harmful Reactive Oxygen Species (ROS), including hydrogen peroxide, accumulate during cell respiration

PMID: 61 NicolauJNadalARosIMasmiquelL